IDYA
Price
$16.35
Change
+$1.58 (+10.70%)
Updated
Apr 2 closing price
Capitalization
1.43B
40 days until earnings call
MGTX
Price
$6.36
Change
+$0.20 (+3.25%)
Updated
Apr 2 closing price
Capitalization
501.52M
35 days until earnings call
Ad is loading...

IDYA vs MGTX

Header iconIDYA vs MGTX Comparison
Open Charts IDYA vs MGTXBanner chart's image
IDEAYA Biosciences
Price$16.35
Change+$1.58 (+10.70%)
Volume$2.15M
Capitalization1.43B
MeiraGTx Holdings
Price$6.36
Change+$0.20 (+3.25%)
Volume$593.78K
Capitalization501.52M
IDYA vs MGTX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. MGTX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and MGTX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IDYA: $16.35 vs. MGTX: $6.36)
Brand notoriety: IDYA and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 216% vs. MGTX: 110%
Market capitalization -- IDYA: $1.43B vs. MGTX: $501.52M
IDYA [@Biotechnology] is valued at $1.43B. MGTX’s [@Biotechnology] market capitalization is $501.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • MGTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than MGTX.

Price Growth

IDYA (@Biotechnology) experienced а -6.25% price change this week, while MGTX (@Biotechnology) price change was -12.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

IDYA is expected to report earnings on May 13, 2025.

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.43B) has a higher market cap than MGTX($502M). MGTX YTD gains are higher at: 4.433 vs. IDYA (-36.381). MGTX has higher annual earnings (EBITDA): -121.84M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. MGTX (104M). IDYA has less debt than MGTX: IDYA (19.2M) vs MGTX (84.8M). MGTX has higher revenues than IDYA: MGTX (33.3M) vs IDYA (7M).
IDYAMGTXIDYA / MGTX
Capitalization1.43B502M285%
EBITDA-323.14M-121.84M265%
Gain YTD-36.3814.433-821%
P/E RatioN/AN/A-
Revenue7M33.3M21%
Total Cash676M104M650%
Total Debt19.2M84.8M23%
FUNDAMENTALS RATINGS
IDYA vs MGTX: Fundamental Ratings
IDYA
MGTX
OUTLOOK RATING
1..100
5680
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
9448
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (60) in the null industry is in the same range as MGTX (64) in the Biotechnology industry. This means that IDYA’s stock grew similarly to MGTX’s over the last 12 months.

IDYA's Profit vs Risk Rating (71) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to MGTX’s over the last 12 months.

IDYA's SMR Rating (95) in the null industry is in the same range as MGTX (99) in the Biotechnology industry. This means that IDYA’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for IDYA (94) in the null industry. This means that MGTX’s stock grew somewhat faster than IDYA’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IDYA (100) in the null industry. This means that MGTX’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAMGTX
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINIX42.240.15
+0.36%
MFS International Intrinsic Value I
LCGFX26.59N/A
N/A
William Blair Large Cap Growth I
HSXCX8.88N/A
N/A
Hartford Schroders Diversified Em Mkts C
HBIOX17.58N/A
N/A
Hartford International Opp HLS IB
SUSIX11.57N/A
N/A
State Street Instl US Equity Inv

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+10.70%
GRI - IDYA
54%
Loosely correlated
-17.33%
KRYS - IDYA
51%
Loosely correlated
+3.68%
RCKT - IDYA
50%
Loosely correlated
+8.43%
IMNM - IDYA
49%
Loosely correlated
+7.19%
XENE - IDYA
49%
Loosely correlated
+2.68%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with CRBU. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+3.25%
CRBU - MGTX
46%
Loosely correlated
+2.37%
AURA - MGTX
45%
Loosely correlated
+4.76%
IDYA - MGTX
44%
Loosely correlated
+10.70%
DNA - MGTX
43%
Loosely correlated
+5.30%
RGNX - MGTX
43%
Loosely correlated
+4.29%
More